This survey study uses the smallest worthwhile difference to assess US and Japanese individuals' willingness to take statins based on expected risk-reduction benefits and burden.
OBJECTIVES:To estimate the effect of initial Elderly Health Check-up (EHC) attendance on the 5-year risk of functional disability or death in community-dwelling older adults in a setting where preventing entry into long-term care (LTC) is a primary health-policy goal. DESIGN:Sequential target trial emulation using a population-based cohort. SETTING AND PARTICIPANTS:Community-dwelling adults aged 75 to 84 years without functional disability and without recent EHC participation, drawn from the Sukagawa Study, a population-based cohort in Sukagawa City, a rural municipality with an aging population in Fukushima Prefecture, Japan, between April 2018 and March 2021. METHODS:We compared initial EHC attendance within a 3-month grace period with nonattendance. The primary outcome was a composite of incident functional disability (LTC certification at care-need level ≥3) or death over 5 years; secondary outcomes were each component, with death treated as dependent censoring for disability. Five-year risks were estimated by inverse probability-weighted pooled logistic regression with 95% CIs. RESULTS:The cohort included 21,484 person-trials from 3096 unique individuals (1001 EHCs, 20,483 non-EHCs). The 5-year composite risk was 20.6% (EHC) vs 26.7% (non-EHC): risk difference, -6.1 percentage points (pp; 95% CI, -11.6 to 0.9); risk ratio, 0.77 (95% CI, 0.57-1.03). Corresponding risk differences were -3.7 pps (95% CI, -10.4 to 3.9) for all-cause mortality and -5.4 pps (95% CI, -12.9 to 0.1) for functional disability alone. CONCLUSIONS AND IMPLICATIONS:The evidence is uncertain about the effect of initial EHC participation on the 5-year risk of functional disability or death; the point estimate is compatible with a modest benefit, but the 95% CI included the null. These findings neither support expansion nor justify discontinuation of the EHC program for preventing entry into LTC, and call for replication in additional cohorts before policy changes are considered.
BACKGROUND:Post-traumatic stress disorder (PTSD) has been reported among both survivors and response workers following large natural disasters. The Japan Disaster Rehabilitation Assistance Team (JRAT) provides rehabilitation-focused support;however, few studies have examined post-traumatic stress symptoms (PTSS) among JRAT members. This study investigated the relationship between PTSS and the physical and mental conditions of JRAT members during support activities. METHODS:A questionnaire on job type, activity location, sleep quality, meal quality, fatigue, physical symptoms, and psychological symptoms was distributed among 23 JRAT members one month after deployment. PTSS were assessed using the Impact of Event Scale-Revised (IES-R), a self-report screening questionnaire. RESULTS:Overall, 27.3% of participants were classified into the probable PTSS group. Compared with the non-probable group, they reported significantly poorer sleep quality, more physical symptoms, and greater fatigue, whereas psychological symptoms were more common in the non-probable group. CONCLUSION:Our findings suggest that limited disaster relief experience, discrepancies between expectations and reality, and stress responses during relief activities may be associated with higher PTSS levels among JRAT members, underscoring the importance of comprehensive management of both physical and mental health across deployment phases.
PURPOSE:This study aimed to assess the potential enhancement of image quality in fast-spin-echo T2-weighted images (FSE-T2WI) with respiratory-gating compared to conventional FSE-T2WI and to clarify how abdominal wall motion affects uterine displacement and consequently impacts image quality. METHODS:One hundred and three women who underwent pelvic MRI using a 3T-MRI scanner were enrolled. FSE-T2WI with and without respiratory-gating was visually assessed for motion-related artifacts, and the image quality was categorized as poor, moderate, or excellent. The uterus was classified as type 1 (on the bladder), type 2 (not on the bladder and not retroflexed), or type 3 (uterus contacting the vertebrae or a retroflexed uterus). The relationships (1) between the abdominal wall and uterine displacements, (2) between the quality of FSE-T2WI with and without respiratory-gating and uterine displacement, and (3) between uterine displacement and types were investigated. RESULTS:Respiratory-gated FSE-T2WI achieved better overall image quality, with poor, moderate, and excellent ratings observed in 27, 44, and 32 patients, respectively, compared with 53, 34, and 16 patients for conventional FSE-T2WI. Improvement with respiratory-gating was observed in 43 patients, particularly in those with type 1 and type 2 uteri, whereas only 8 patients showed decreased image quality. A strong correlation was found between abdominal wall and uterine displacements (P < 0.001), indicating that uterine motion is largely driven by respiration. The amplitude of uterine displacement was significantly smaller in type 3 uteri (P < 0.05), consistent with fewer motion-related artifacts. CONCLUSION:Respiratory-gated FSE-T2WI effectively reduces motion artifacts caused by respiratory-induced uterine displacement, particularly in type 1 and type 2 uteri where displacement is pronounced.
Abstract Background Neuroinflammation has been proposed as a key pathophysiological mechanism underlying treatment-resistant schizophrenia (TRS). Interleukin-6 (IL-6) has been reported as a trait-related inflammatory marker in schizophrenia; however, data focusing specifically on TRS and the impact of clozapine treatment remain limited. Aims & Objectives The aim of the present study was to investigate differences in plasma IL-6 levels between TRS and antipsychotic-responsive schizophrenia (AR). Specifically, we aimed to clarify the associations between plasma IL-6 levels and clinical symptoms, cognitive function, and clozapine treatment in TRS. Method We conducted a multicenter cross-sectional study including patients with TRS and AR. Plasma IL-6 levels were measured and compared between the two groups. Cognitive function and clinical variables were assessed, and factors associated with plasma IL-6 levels were examined within the TRS group. Results A total of 62 patients (37 patients with TRS and 25 with AR) were included. Plasma IL-6 levels were significantly higher in TRS than in AR (p < 0.001). Within the TRS group, plasma IL-6 levels were negatively associated with the duration of clozapine treatment (r = −0.348, p < 0.05; Figure1). This association remained significant after adjustment for age in multiple regression analysis (β = −0.435, p = 0.007). No significant associations were observed between plasma IL-6 levels and symptom severity or cognitive function within the TRS group. Discussion & Conclusions These findings support the concept that TRS represents a biologically distinct subtype of schizophrenia characterized by inflammatory dysregulation. Moreover, longer-term clozapine treatment may exert anti-inflammatory effects in TRS, highlighting a potential immunomodulatory role of clozapine beyond symptom control. Further longitudinal studies are warranted to clarify the causal relationship between clozapine treatment and inflammatory processes.